JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 1,768 articles

Articles by James Calloway

Genmab Shares Slide on Profit Dip Despite Strong Revenue Growth
Earnings

Genmab Shares Slide on Profit Dip Despite Strong Revenue Growth

Genmab shares tumbled nearly 10% in Copenhagen after Q1 net profit plunged to $53M, weighed down by Merus deal costs and elevated R&D, despite a 25% revenue surge to $896M.

Coinbase Posts Q1 Loss as Crypto Slowdown Squeezes Revenue
Earnings

Coinbase Posts Q1 Loss as Crypto Slowdown Squeezes Revenue

Coinbase swung to a $394.1 million Q1 loss as revenue fell 31%, hit by a crypto trading slowdown and an AWS outage. The exchange also plans to cut 700 jobs.

COIN AMZN
Akamai Stock Surges on $1.8B AI Cloud Deal
Earnings

Akamai Stock Surges on $1.8B AI Cloud Deal

Akamai shares surged 26% premarket after announcing a $1.8B, seven-year AI cloud deal, its largest ever, signaling strong traction in AI infrastructure.

AKAM
Block Raises 2026 Gross Profit Outlook to $12.33B on Cash App Strength
Earnings

Block Raises 2026 Gross Profit Outlook to $12.33B on Cash App Strength

Block Inc raised its 2026 gross profit target to $12.33 billion after strong Q1 growth from Cash App and Square. Shares rose 7.7% after hours despite a $308.7 million net loss and $240 million DOJ-related accrual.

SQ
HubSpot Shares Slide Despite Q1 Beat as AI Pricing Shift Extends Sales Cycles
Earnings

HubSpot Shares Slide Despite Q1 Beat as AI Pricing Shift Extends Sales Cycles

HubSpot beat Q1 estimates but shares dropped 11.9% as AI pricing shifts lengthen sales cycles. Revenue rose 23% to $881M, but Q2 outlook disappointed.

HUBS
Shake Shack Tumbles 30% on Q1 Loss, Rising Beef Costs, and CFO Change
Earnings

Shake Shack Tumbles 30% on Q1 Loss, Rising Beef Costs, and CFO Change

Shake Shack shares fell up to 30% after reporting a Q1 net loss, missing revenue estimates, and naming a new CFO. Rising beef costs and higher operating expenses pressured margins.

SHAK
Marvell Technology Drops 7% as AI Chip Rally Faces Key Earnings Test
Earnings

Marvell Technology Drops 7% as AI Chip Rally Faces Key Earnings Test

Marvell Technology shares slid 7% as the AI chipmaker's rally hits a pause ahead of its May 27 earnings report, despite strong data-center demand and a $2 billion Nvidia investment.

MRVL NVDA AVGO
Datadog Crosses $1B in Quarterly Revenue, Shares Surge on AI Demand
Earnings

Datadog Crosses $1B in Quarterly Revenue, Shares Surge on AI Demand

Datadog posted Q1 revenue above $1 billion for the first time, jumping 32% to $1.006 billion, and raised its 2026 sales forecast. Shares soared $45.02 to $188.73.

DDOG
Humana Stock Rally Tests Valuation as Profit Forecast Slips
Earnings

Humana Stock Rally Tests Valuation as Profit Forecast Slips

Humana lowered its 2026 GAAP EPS forecast to at least $8.36, while its stock has surged over 25% in a month, pushing the P/E ratio above 26.

HUM UNH CVS
Innodata Shares Surge on Q1 Beat, AI Data Demand Drives Outlook Upgrade
Earnings

Innodata Shares Surge on Q1 Beat, AI Data Demand Drives Outlook Upgrade

Innodata shares surged 29% after hours as Q1 revenue and profit topped estimates, driven by a major new AI data contract that lifted the 2026 growth outlook to at least 40%.

INOD
NuScale Power Stock Tumbles 8.7% After Q1 Loss Deepens, Cash Burn Intensifies
Earnings

NuScale Power Stock Tumbles 8.7% After Q1 Loss Deepens, Cash Burn Intensifies

NuScale Power shares dropped 8.7% after hours Thursday after reporting a wider Q1 loss and a 96% revenue decline to $565,000, with cash burn of $314.7 million.

SMR
Agilon Health Stock Surges 118% on Q1 Profit Beat, New CEO Appointed
Earnings

Agilon Health Stock Surges 118% on Q1 Profit Beat, New CEO Appointed

Agilon Health shares jumped 118% to $60.66 after a strong Q1 earnings beat, with net income rising to $49M. The company also raised its 2026 forecast and appointed Tim O'Rourke as CEO.

AGL